Epigenetic Insights into Substance Use Disorder and Associated Psychiatric Conditions
- PMID: 40201238
- PMCID: PMC11975344
- DOI: 10.1159/000544912
Epigenetic Insights into Substance Use Disorder and Associated Psychiatric Conditions
Abstract
Background: Substance use disorder (SUD) is closely associated with epigenetic modifications that significantly impact mental health outcomes. Alcohol and drug misuse induce widespread changes in the epigenome and transcriptome of the central nervous system, disrupting critical processes such as reward signaling and emotional regulation. These alterations in epigenetic regulation and gene expression often persist even after substance cessation, potentially contributing to the onset or worsening of psychiatric conditions, including schizophrenia, depression, stress, and anxiety.
Summary: This review delves into key epigenetic mechanisms underlying SUD and its comorbid psychiatric disorders, with a focus on DNA methylation, histone modifications, and noncoding RNA regulation. Additionally, it examines the influence of environmental and biological factors on the epigenome and evaluates emerging epigenetic-based therapeutic strategies aimed at treating SUD and related psychiatric conditions.
Key messages: Gaining a deeper understanding of the epigenetic mechanisms driving SUD and its associated psychiatric disorders is crucial for the development of effective therapeutic interventions. This review highlights the potential of epigenetic-based pharmacological strategies to mitigate the societal and personal burdens linked to SUD and its mental health complications.
Keywords: Comorbidity; Epigenetics; Psychiatric conditions; Substance use disorder.
© 2025 S. Karger AG, Basel.
Conflict of interest statement
Dr. Huiping Zhang is a board member of Complex Psychiatry.
Similar articles
-
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383. Med J Aust. 2019. PMID: 31679171
-
Epigenomics in stress tolerance of plants under the climate change.Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9. Mol Biol Rep. 2023. PMID: 37294468 Review.
-
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review.Front Psychiatry. 2024 Nov 18;15:1508732. doi: 10.3389/fpsyt.2024.1508732. eCollection 2024. Front Psychiatry. 2024. PMID: 39624511 Free PMC article.
-
[Epigenetics of schizophrenia: a review].Encephale. 2014 Oct;40(5):380-6. doi: 10.1016/j.encep.2014.06.005. Epub 2014 Aug 12. Encephale. 2014. PMID: 25127897 Review. French.
-
Cell-type specific epigenetic and transcriptional mechanisms in substance use disorder.Front Cell Neurosci. 2025 Mar 28;19:1552032. doi: 10.3389/fncel.2025.1552032. eCollection 2025. Front Cell Neurosci. 2025. PMID: 40226298 Free PMC article. Review.
References
-
- Volkow ND, Morales M. The brain on drugs: from reward to addiction. Cell. 2015;162(4):712–25. - PubMed
-
- NIDA . Common comorbidities with substance use disorders research report. Bethesda (MD): National Institutes on Drug Abuse (US); 2020.
Publication types
LinkOut - more resources
Full Text Sources